Literature DB >> 33401332

Hemostasis in Coronavirus Disease 2019-Lesson from Viscoelastic Methods: A Systematic Review.

Artur Słomka1, Mariusz Kowalewski2,3,4, Ewa Żekanowska1.   

Abstract

Hemostatic unbalance is often observed in patients with coronavirus disease 2019 (COVID-19), and patients with severe disease are at high risk of developing thromboembolic complications. Viscoelastic methods (VEMs), including thrombelastography (TEG) and thromboelastometry (TEM), provide data on the nature of hemostatic disturbance. In this systematic review, we assessed the performance of TEG and TEM in the assessment of blood coagulation and fibrinolysis in patients with COVID-19. PubMed, Scopus, Web of Science Core Collection, medRxiv, and bioRxiv were systematically searched for clinical studies evaluating TEG and/or TEM variables in COVID-19 individuals. Ten studies, with a total of 389 COVID-19 patients, were included, and VEMs were performed in 292 of these patients. Most patients (90%) presented severe COVID-19 and required mechanical ventilation. TEG and TEM variables showed that these patients displayed hypercoagulability and fibrinolysis shutdown, despite the use of appropriate thromboprophylaxis. However, the mechanism underlying these phenomena and their clinical significance in COVID-19 patients who developed thrombosis are still not clear. Further studies are warranted if VEMs might help to identify those at highest risk of thrombotic events and who therefore may derive the greatest benefit from antithrombotic therapy. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33401332     DOI: 10.1055/a-1346-3178

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   6.681


  12 in total

1.  No Evidence for Classic Thrombotic Microangiopathy in COVID-19.

Authors:  Tanja Falter; Heidi Rossmann; Philipp Menge; Jan Goetje; Steffen Groenwoldt; Arndt Weinmann; Visvakanth Sivanathan; Andreas Schulz; Niels A W Lemmermann; Sven Danckwardt; Karl J Lackner; Peter R Galle; Inge Scharrer; Bernhard Lämmle; Martin F Sprinzl
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

Review 2.  Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects.

Authors:  Daniella M Mizurini; Eugenio D Hottz; Patrícia T Bozza; Robson Q Monteiro
Journal:  Front Cardiovasc Med       Date:  2021-12-17

Review 3.  Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Stefanie Reis; Maria Popp; Benedikt Schmid; Miriam Stegemann; Maria-Inti Metzendorf; Peter Kranke; Patrick Meybohm; Stephanie Weibel
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

Review 4.  Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices.

Authors:  Oksana Volod; Connor M Bunch; Nuha Zackariya; Ernest E Moore; Hunter B Moore; Hau C Kwaan; Matthew D Neal; Mahmoud D Al-Fadhl; Shivani S Patel; Grant Wiarda; Hamid D Al-Fadhl; Max L McCoy; Anthony V Thomas; Scott G Thomas; Laura Gillespie; Rashid Z Khan; Mahmud Zamlut; Peter Kamphues; Dietmar Fries; Mark M Walsh
Journal:  J Clin Med       Date:  2022-02-07       Impact factor: 4.241

5.  Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.

Authors:  Christopher D Barrett; Hunter B Moore; Ernest E Moore; Janice Wang; Negin Hajizadeh; Walter L Biffl; Lawrence Lottenberg; Purvesh R Patel; Michael S Truitt; Robert C McIntyre; Todd M Bull; Lee Anne Ammons; Arsen Ghasabyan; James Chandler; Ivor S Douglas; Eric P Schmidt; Peter K Moore; Franklin L Wright; Ramona Ramdeo; Robert Borrego; Mario Rueda; Achal Dhupa; D Scott McCaul; Tala Dandan; Pralay K Sarkar; Benazir Khan; Coimbatore Sreevidya; Conner McDaniel; Heather M Grossman Verner; Christopher Pearcy; Lorenzo Anez-Bustillos; Elias N Baedorf-Kassis; Rashi Jhunjhunwala; Shahzad Shaefi; Krystal Capers; Valerie Banner-Goodspeed; Daniel S Talmor; Angela Sauaia; Michael B Yaffe
Journal:  Chest       Date:  2021-09-27       Impact factor: 9.410

6.  Novel Coronavirus Infection (COVID-19) Related Thrombotic and Bleeding Complications in Critically Ill Patients: Experience from an Academic Medical Center.

Authors:  Thejus Jayakrishnan; Aaron Haag; Shane Mealy; Corbyn Minich; Abraham Attah; Michael Turk; Nada Alrifai; Laith Alhuneafat; Fadi Khoury; Adeel Nasrullah; Patrick Wedgeworth; Melissa Mosley; Kirtivardan Vashistha; Veli Bakalov; Abhishek Chaturvedi; Swathi Sangli
Journal:  J Clin Med       Date:  2021-11-30       Impact factor: 4.241

7.  Routine and Advanced Laboratory Tests for Hemostasis Disorders in COVID-19 Patients: A Prospective Cohort Study.

Authors:  Paul Billoir; Perrine Leprêtre; Caroline Thill; Jeremy Bellien; Veronique Le Cam Duchez; Jean Selim; Fabienne Tamion; Thomas Clavier; Emmanuel Besnier
Journal:  J Clin Med       Date:  2022-03-03       Impact factor: 4.241

8.  Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19.

Authors:  Yesha H Parekh; Nicole J Altomare; Erin P McDonnell; Martin J Blaser; Payal D Parikh
Journal:  Viruses       Date:  2021-05-11       Impact factor: 5.048

Review 9.  Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review.

Authors:  Taylor J Louis; Ahmad Qasem; Latifa S Abdelli; Saleh A Naser
Journal:  Microorganisms       Date:  2022-01-12

Review 10.  The Composition and Physical Properties of Clots in COVID-19 Pathology.

Authors:  Sierk Dauwerse; Hugo Ten Cate; Henri M H Spronk; Magdolna Nagy
Journal:  Diagnostics (Basel)       Date:  2022-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.